BRCC3 and myelodysplastic syndrome: Namely, DNMT3A p.R899C and BRCC3 p.Q299* have been reported with a VAF = 2% in patients with MDS and were found with a VAF equal to 1.8% and 1% in our COV-ICU patients, respectively.